Lockheed Martin Investment Management Co. Invests $2.70 Million in Regeneron Pharmaceuticals, Inc. $REGN

Lockheed Martin Investment Management Co. has invested $2.70 million in Regeneron Pharmaceuticals, Inc. by acquiring 3,500 shares in the fourth quarter. This comes as Regeneron reported robust quarterly results, with EPS of $9.47 and revenue of $3.61 billion, alongside declaring a $0.94 quarterly dividend. Analysts generally maintain a "Moderate Buy" rating with a consensus price target of $826.59 for the company.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned